LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported third-quarter net income of $128.1 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Lexington, Massachusetts-based company said it had net income of $5.44. Losses, adjusted for non-recurring gains, came to 70 cents per share.
The biopharmaceutical company posted revenue of $143.8 million in the period. Its adjusted revenue was $17,000.
Concert shares have risen 60 percent since the beginning of the year. The stock has more than doubled in the last 12 months.